Trial intelligence / Profile preview

Vitamin D Supplementation in Early-Stage Prostate Cancer

NCT00953225Phase 2Completed

Sponsor
VA Office of Research & Development
Start
Jan 2010
Primary completion
Dec 2013
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

A Phase 2 trial of vitamin d in prostate cancer (PCa), sponsored by VA Office of Research & Development. Started Jan 2010; status: completed.

02

Drugs

vitamin d
03

Conditions

prostate cancer (PCa)

Beyond the preview

Go deeper on NCT00953225.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00953225.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call